Navigation Links
Embolic in Medical News

Abbott Announces Launch of Next-Generation Embolic Protection System

Emboshield NAV6(TM) Demonstrates Abbott's Continued Leadership in Carotid Therapy ABBOTT PARK, Ill., June 12 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT ) today announced the launch of the sixth-generation Emboshield NAV6(TM) Embolic Protection System for use in carotid artery stenting proc...

NEJM study demonstrates carotid stenting with embolic protection is comparable to surgery

WARREN, N.J., April 9, 2008 According to a study published in The New England Journal of Medicine this week, three-year data from the Stenting and Angioplasty with Protection in Patients at High Risk for Endarterectomy (SAPPHIRE) study in patients with severe blocked carotid arteries, the main bl...

Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009

...elf-expanding and balloon-expanding peripheral stents, including the Absolute Pro and Omnilink Elite Peripheral Stent Systems, and the Emboshield Nav6 embolic Protection Device for carotid stenting. ...

Avoiding Hysterectomy: Major Interventional Radiology E-collection Info Available

... a randomized study by Gary P. Siskin, M.D., FSIR, and colleagues at Albany Medical College, that answers a key technical question regarding choice of embolic material. Also important are "Economic Evaluation of Uterine Artery Embolization Versus Hysterectomy in the Treatment of Symptomatic Uterine Fibroids:...

Abbott Announces EuroPCR 2009 Activities

...ssel closure device with this indication in the European Union. Emboshield Nav6 : Abbott will feature its sixth-generation Emboshield(R) NAV6 embolic Protection System, which is used during carotid stenting procedures to prevent particles of dislodged plaque from flowing to the brain, potentially ca...

Kensey Nash Reports Third Quarter and First Nine Month Fiscal Year 2009 Results

... 2008 also included after-tax charges of $2.2 million ($3.3 million pre-tax) for the acceleration of stock awards and discontinuation of the Company's embolic protection platform. In the nine-month period ended March 31, 2009, the total tax-effected impact on earnings per share of equity compensation ...

Abbott Reports 16 Percent Earnings Growth in First Quarter; Confirms Double-Digit Earnings Growth Outlook for 2009

...elf-expanding and balloon-expanding peripheral stents, including the Absolute Pro and Omnilink Elite Peripheral Stent Systems, and the Emboshield Nav6 embolic Protection Device for carotid stenting. ...

Abbott Initiates U.S. Study of Absolute Pro(TM) Peripheral Stent System for Iliac Artery Disease

...e, and coronary artery disease. Key products in the vascular pipeline include: the Omnilink Elite(TM) Peripheral Stent System; the EMBOSHIELD NAV6(TM) embolic Protection System for carotid stenting; a fully bioabsorbable drug eluting coronary device; and the XIENCE PRIME(TM) Everolimus Eluting Coronary Stent...

New Device Treats Common Heart Rhythm Disorder

...ts are receiving the safest and most effective dose because it can cause serious bleeding if given in doses that are too high, Holmes noted. In the embolic Protection in Patients With Atrial Fibrillation (PROTECT AF) trial, researchers compared treatment with warfarin to a fabric-covered, expandable cage ...

Study Shows 80% of Adults with Peripheral Arterial Disease Go Undiagnosed

...will drive sales for PAD treatment devices, particularly for devices such as stents and stent-grafts, and complementary and alternative products, like embolic protection and atherectomy devices." In 2008, the largest segment in the U.S. market for peripheral vascular devices was for stents, which represent...
Embolic in Medical Technology

Analysis of Edoxaban Phase II Data Provides Insight Into Reduced Bleeding Events Seen in Once-Daily Dosing

...h Factor Xa Next Generation in Atrial Fibrillation (ENGAGE-AF), is comparing edoxaban with warfarin (INR2-3) for the prevention of stroke and systemic embolic events (SEE) in patients with atrial fibrillation. Edoxaban is also being studied for treatment of VTE, and for the prevention of DVT after major ort...

InspireMD Announces the Enrollment of the 1st Patient in the MGuard iMOS Registry, the Registry Will Enroll 1000 Patients

...vel combination of a coronary stent merged with an embolic protection. The embolic protection is comprised of an ultra-thin polymer m.... The MGuard(TM) coronary stent provides permanent embolic protection, without complicating deliverability. R...

Video: ev3 Inc. Announces First Patient Enrollments in DEFINITIVE LE Post-Market Study

...ckHawk) Plaque Excision System and the SpiderFX(R) embolic Protection Device in the endovascular treatment of...oplasty balloons, stents, plaque excision systems, embolic protection devices, liquid embolics, embolization ...the SilverHawk plaque excision system and SpiderFX embolic protection device, future regulatory submissions a...

Abbott Advances Its Revolutionary Fully Bioabsorbable Drug Eluting Stent With Initiation of Next Phase of Clinical Trial

...e, and coronary artery disease. Key products in the vascular pipeline include: the Omnilink Elite(TM) Peripheral Stent System; the EMBOSHIELD NAV6(TM) embolic Protection System for carotid stenting; and the XIENCE PRIME(TM) Everolimus Eluting Coronary Stent System, which builds upon the proven performance of...

MGuard(TM) Coronary Stent System Approved in Israel

...vel combination of a coronary stent merged with an embolic protection device. Lifelong embolic protection is achieved by an expandable, flexible ...at wraps the stent. In addition, MGuard(TM) blocks embolic showers and plaque detachment from the arterial wa...

Daiichi Sankyo Initiates Phase III Trial of Its Investigational Factor Xa Inhibitor, DU-176b, in Patients With Atrial Fibrillation

...lation with Factor Xa Next Generation in Atrial Fibrillation (ENGAGE-AF TIMI 48), will compare DU-176b with warfarin in preventing stroke and systemic embolic events (SEE) in patients with atrial fibrillation. The primary safety assessment will be the incidence of bleeding. Results from a recently p...

Valor Medical Reports Early Clinical Results of New Technology to Treat Cerebral Aneurysms

...iology Conference in New Orleans the early results on the use of a new technology, Neucrylate(TM), to treat cerebral aneurysms. Neucrylate is a liquid embolic that has been developed by Valor Medical, a San Diego, CA, medical device company. "The patients have had very positive results and to date the accumu...

Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results

...'s NexStent(R) Carotid Stent and FilterWire EZ(TM) embolic Protection System, but also a longer-term benefit ...d Stent when used with the Company's FilterWire EZ embolic Protection System in treating patients at high ris...NT(R) Monorail(R) Endoprosthesis and FilterWire EZ embolic Protection System. CABERNET and BEACH were both pr...

Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007

...(R) Carotid Stent System and FilterWire EZ(TM) embolic Protection System, which received FDA approval...on with the FilterWire EX(R) and FilterWire EZ(TM) embolic Protection Systems in the treatment of high su... The safety and effectiveness of the FilterWire EZ embolic Protection System for use in carotid arteries has ...

Abbott Initiates Clinical Study to Evaluate Use of RX Herculink(R) Elite(TM) Renal Stent System for the Treatment of Renal Artery Stenosis

... analyses in patient follow-up visits out to 36 months will measure major adverse events in patients such as death, surgical removal of the kidney, or embolic events resulting in kidney damage, as well as target lesion revascularization (TLR), a measure of the need to retreat a diseased vessel that has renar...
Embolic in Medical Products

Onyx® Liquid Embolic System

Description: Onyx Liquid Embolic System is a device utilized for the pre-surgical embolization of arteriovenous malformations (AVMs)....
Company:ev3, Inc.

SpideRX® Embolic Protection Device

Description: The SpideRX Embolic Protection Device features the ability to use a separate, preferred guidewire to cross the lesion and a pre-loaded nitinol filter with a dual-ended catheter for delivery and recovery. Offering a fully rapid exchange system, the SpideRX Device is easy to use in the indicated appl...
Company:ev3, Inc.

Emboshield BareWire Embolic Protection System

Description: With BareWire technology, the wire crosses the lesion first, independent of the filter and delivery catheter. All other actions, including filter placement and retrieval, balloon dilatations, and stent placement then occur over the wire....
Company:Abbott Vascular

Emboshield(R) Embolic Protection System

Description: With BareWire technology, the wire crosses the lesion first, independent of the filter and delivery catheter. All other actions, including filter placement and retrieval, balloon dilatations, and stent placement then occur over the wire. Emboshield is designed to capture emboli that can break...
Company:Abbott Vascular

RX ACCUNET Embolic Protection System

Description: The RX ACCUNET Embolic Protection System is designed to provide excellent capture capabilities and easy filter control when performing carotid stenting interventions. The ACCUNET is a .014 guide wire based filter system that utilizes rapid exchange technology so that the physician can easily contro...
Company:Guidant Corporation

FilterWire EZ Embolic Protection System

Description: Predictable Protection Made Easy. The new generation FilterWire EZ System has focused improvements on effectiveness and ease of use, providing you with the confidence of greater predictability for SVG stenting and angioplasty procedures. The FilterWire EZ System adds predictability to the pro...
Company:Boston Scientific Corporation

Proxis Embolic Protection System

Description: Proxis features 'proximal protection' -- providing complete protection from initial crossing to device removal, even in vessels with side branches. Proxis is fast and easy to use. It does not require the attachment or exchange of extra devices for removal of embolic debris. Proxis is...
Company:Velocimed, Inc.

ANGIOGUARD Capture Guidewire

Description:... The Cordis ANGIOGUARD Capture Guidewire is the first embolic protection device shown in clinical testing to achieve a relative stroke reduction of 70% during carotid stenting procedures....
Company:AMTSystems

ANGIOGUARD® Capture Guidewire

Description:... The Cordis ANGIOGUARD® Capture Guidewire is the first embolic protection device shown in clinical testing to achieve a relative stroke reduction of 70% during carotid stenting procedures....
Company:Cordis Corporation

RX ACCULINK Carotid Stent System

Description:...ter compatible for all available stent sizes. The RX ACCULINK utilizes rapid exchange (RX) technology so that a single operator can easily control the embolic protection device and stent delivery system during catheter manipulations....
Company:Abbott Vascular

More>>

Embolic in Medical Dictionary

Thrombolytic therapy

...For thrombolytic therapy to be effective in treating stroke or heart attack, ... during intraarterial thrombolytic therapy for acute embolic ... Intraarterial thrombolytic therapy is a recog- nized treatment option in the setting of acute ... Thrombolytic Therapy Antithrombo...

Carotid

...n for physicians on carotid artery stenting procedures and training. ... Learn more about the Carotid WALLSTENT Endoprosthesis and FilterWire EZ embolic ... Carotid endarterectomy is a vascular surgery procedure that removes plaque from ... Carotid artery disease is a serious issue beca...

Acute arterial occlusion

...l occlusion of the kidney may occur after injury or ... Acute arterial occlusion due to an embolus differs from atherosclerotic ... embolic arterial occlusion is an emergency, generally requiring treatment ... Acute arterial occlusion of the kidney is a sudden, severe blo...
Embolic in Biological News

Avoiding hysterectomy: Major interventional radiology E-collection info available

... a randomized study by Gary P. Siskin, M.D., FSIR, and colleagues at Albany Medical College, that answers a key technical question regarding choice of embolic material. Also important are "Economic Evaluation of Uterine Artery Embolization Versus Hysterectomy in the Treatment of Symptomatic Uterine Fibroids:...

2 carotid artery stenting studies show results comparable to AHA guidelines

...nts and utilized Abbott's ACCULINK(tm) Carotid Stent System and ACCUNET(tm) embolic Protection System. The EXACT study included 2,124 patients and utilized Abb...id Exchange Carotid Stent System and Emboshield BareWire(tm) Rapid Exchange embolic Protection System. The key objective of both trials was to determine whethe...
Embolic in Biological Technology

Boston Scientific Announces Launch of Expanded Size Range of FilterWire EZ(TM) Embolic Protection System

New size allows for treatment of smaller-diameter diseased saphenous vein grafts NATICK, Mass., May 19 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today announced the launch of its FilterWire EZ(TM) Embolic Protection System in a new 2.2...

CeloNova BioSciences Announces World's First Line of Fully Color-Coded Embolic Particles at CIRSE: Embozene(TM) Color-Advanced Microspheres

ATLANTA, Sept. 8 /PRNewswire/ -- CeloNova BioSciences, Inc. ("CeloNova"), a leading developer of innovative medical devices, today unveiled the world's first fully color-coded line of embolic particles, Embozene(TM) Color-Advanced Microspheres, at the annual meeting of the Cardiovascular and I...

Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009

...cal procedure, trauma patients or patients that have experienced a previous embolic event. IVC filters have been shown in several studies to significantly redu...ertain high risk patient populations. In certain cases, once the risk of an embolic event has passed, the IVC filter will be removed in a subsequent surgical p...

InspireMD Announce the Completion of Enrollment for the MAGICAL Trial (MGuard(TM) in Acute Myocardial Infarction) at EuroPCR '09. Results Will be Presented May 21st by Dr. Dariusz Dudek at the InspireMD Cocktail Reception Debate Chaired by Prof. Martin Le

...vel combination of a coronary stent merged with an embolic protection. The embolic protection is comprised of an ultra-thin polymer m.... The MGuard(TM) coronary stent provides permanent embolic protection, without complicating deliverability. R...

Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results

... stock awards and discontinuation of the Company's embolic protection platform. Including these items, dilut... related to the discontinuation of the Company's embolic protection platform, both of which were incurr...elated to the discontinuation of the Company's embolic protection platform, both of which were incurr...

First U.S. Implants of Newly Approved Embozene(TM) Color-Advanced Microspheres Embolization Platform

...in a wider range of sizes than any other spherical embolic on the market. They are available in 40, 100, 250,...nt, and precise for the operator. The result is an embolic microsphere that provides accurate and complete ve...r the qualities and characteristics that the ideal embolic device should have. Then, we engineered in those p...

ev3 Inc. Receives FDA Clearance to Market EverCross and NanoCross Peripheral Angioplasty Balloons

...f treatment options, including the primary interventional technologies used today -- peripheral angioplasty balloons, stents, plaque excision systems, embolic protection devices, liquid embolics, embolization coils, thrombectomy catheters and occlusion balloons. More information about the company and its pr...

ev3 Inc. Appoints John L. Miclot to Board of Directors

...f treatment options, including the primary interventional technologies used today -- peripheral angioplasty balloons, stents, plaque excision systems, embolic protection devices, liquid embolics, embolization coils, thrombectomy catheters and occlusion balloons. More information about the company and its pr...

MGuard(TM), InspireMD's Novel Coronary Stent System, was Celebrated by World Leading Interventional Cardiologists at the Transcatheter Cardiovascular Therapeutics (TCT) in Washington DC, USA, October 12-17 2008

...vel combination of a coronary stent merged with an embolic protection device. The embolic protection device i...issues of current stenting procedures: restenosis, embolic showers, and late thrombosis. In addition to providing embolic protection and minimizing arterial injury, this pr...

Valor Medical Closes $1.4 Million Convertible Debt and Receives ISO 13485 Certification

... SAN DIEGO, Nov. 6 /PRNewswire/ -- Valor Medical, Inc., a medical device company that has developed a liquid embolic technology for the treatment of cerebral aneurysms, announced today that they have successfully raised $1.4 million in capital through a convertible d...
Embolic in Biological Dictionary

Lumen

...s ... to detail and the colorful graphics make Lumen a joy to play. ... Lumen is very simple and ... FDA Approves Lumen Biomedical's FiberNet embolic Protection System for Carotid Artery Stenting ... Lumen Biomedical Receives FDA Clearance of Embolectomy ... MySpace Music profile for LUMEN . D...
Other Tags
(Date:7/14/2014)... 2014 Acute coronary syndrome (ACS) ... healthcare costs, frequent recurrences and hospitalizations, and high ... ACS incidence increases with age and will be ... population increases around the world. ACS is classified ... heart muscle damage inferred from a person’s symptoms, ...
(Date:7/14/2014)... 14, 2014 Georgia State University ... groups under the fifth round of its Second ... of research and academic performance. , The ... of top-notch faculty members to the university, with ... in areas of national significance. , “With the ...
(Date:7/14/2014)... through the bloodstream, homing in on a sheath ... and metastasize to other organs, scientists at The ... in Cancer Cell . , "This completely ... provides new potential avenues to predict and prevent ... M.D., professor of Gynecologic Oncology and Reproductive Medicine ...
(Date:7/14/2014)... look back on 40 years of the Glasgow Coma Scale ... and clinical practice, in a new Personal View published in ... Personal View is published on the 40th anniversary of the ... Since this seminal publication, the Glasgow Coma Scale has provided ... level, the clinical hallmark of acute brain injury. The scale ...
(Date:7/14/2014)... D.C., July 14, 2014 A recent study published ... of the American Academy of Child and Adolescent Psychiatry ... the age of onset criterion for diagnosis of attention-deficit/hyperactivity ... for ADHD, previously set at 7 in DSM-IV, has ... of onset is now set at 12, rather than ...
Breaking Medicine News(10 mins):Health News:Acute Coronary Syndrome (ACS) Incident Cases to Reach 1.47 million by 2023, Says a New Report Available at ReportsnReports.com 2Health News:Acute Coronary Syndrome (ACS) Incident Cases to Reach 1.47 million by 2023, Says a New Report Available at ReportsnReports.com 3Health News:Acute Coronary Syndrome (ACS) Incident Cases to Reach 1.47 million by 2023, Says a New Report Available at ReportsnReports.com 4Health News:Georgia State Starts Four Innovative Research Groups Through Fifth Round of Its Second Century Initiative 2Health News:Georgia State Starts Four Innovative Research Groups Through Fifth Round of Its Second Century Initiative 3Health News:MD Anderson researchers discover new route for ovarian cancer spread 2Health News:MD Anderson researchers discover new route for ovarian cancer spread 3
(Date:7/14/2014)... have shown how the main psychoactive ingredient in cannabis ... Research published today reveals the existence of previously unknown ... in shrinking tumours. , It is hoped that ... anti-cancer properties. , The research was co-led ... used samples of human breast cancer cells to induce ...
(Date:7/13/2014)... release is available in French . ... An international research project, led by the Research ... Montreal, reports that a new oral medication is showing ... congenital amaurosis (LCA). Until now, this inherited retinal disease ... complete blindness, has remained untreatable. The study is published ...
(Date:7/11/2014)... eastern New South Wales, Australia when NASA,s Aqua satellite ... on July 11 (12:35 p.m. local time/11:35 p.m. EDT ... South Wales (NSW), the Moderate Resolution Imaging Spectroradiometer (MODIS) ... and spotted smoke (light brown) from various fires. Actively ... in red. , The New South Wales, Australia Government ...
Breaking Biology News(10 mins):UEA research reveals how cannabis compound could slow tumour growth 2MUHC researcher unveils novel treatment for a form of childhood blindness 2
Other Contents